City of Hope-製薬・医療分野:企業M&A・提携分析

GlobalDataが発行した調査報告書(DATA8014050)
◆英語タイトル:City of Hope - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014050
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:48
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
City of Hope (COH) is a biomedical research organization that offers cancers, diabetes and infectious diseases treatment services. The organization offers services in the fields of anesthesiology, interventional radiology, surgery, donor matching and marrow transplants, rehabilitation services and pathology, among others. It conducts research and development to develop treatments for cancer fighting drugs, avastin, herceptin, and rituxan. COH also offers educational services for post doctoral fellowships through its affiliates. The organization also provides clinical trial services. Its community practice site includes Arcadia, Corona, Mission Hills, Arcadia Radiation Oncology, Santa Clarita, Palm Springs, Simi Valley, Colton, Glendora, Pasadena, and others. The orgaization operates in Duarte, Rancho Cucamonga, Simi Valley, Santa Clarita, Mission Hills, Pasadena, Arcadia, Glendora, and West Covina. COH is headquartered in Duarte, California, the US.

City of Hope – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
City of Hope, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
City of Hope, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
City of Hope, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
City of Hope, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
City of Hope, Medical Devices Deals, 2011 to YTD 2017 10
City of Hope, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
City of Hope, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Helocyte Enters into Agreement with City of Hope for PepVax 13
Helocyte Enters into Agreement with City of Hope 14
Sorrento Therapeutics forms Joint Venture with City of Hope 15
Coronado Biosciences Forms Joint Venture with City of Hope 16
ModiQuest Research Enters Into Research Agreement With Beckman Research Institute 17
Licensing Agreements 18
Mustang Bio Enters into Licensing Agreement with City of Hope 18
City of Hope Signs Licensing Agreement with Homology Medicines 19
Helocyte Exercises Option for Licensing Agreement with City of Hope for Pentamer 20
Mustang Bio Enters into Licensing Agreement with City of Hope 21
Helocyte Amends Agreement with City of Hope National Medical Center 22
Akriveia Therapeutics Enters into Licensing Agreement with City of Hope and Thomas Jefferson University 23
Beckman Research Institute Enters into Licensing Agreement with CEVEC Pharma 24
Tara Immuno-Oncology Therapeutics Enters into Licensing Agreement with City of Hope 25
Sorrento Therapeutics Enters into Licensing Agreement with City of Hope 26
Novonco Pharma Enters into Licensing Agreement with City of Hope 27
ES Cell International Enters into Licensing Agreement with Beckman Research Institute 28
City of Hope – Key Competitors 29
City of Hope – Key Employees 30
City of Hope – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Joint Venture 33
Recent Developments 34
Government and Public Interest 34
Apr 17, 2017: City Of Hope Researchers Successfully Prevent Graft-Versus-Host Disease While Preserving Strong Graft Versus Leukemia Effects In Preclinical Study 34
Mar 07, 2017: Researchers Study Cure for Type 1 Diabetes in Stem Cell Transplantations 36
Sep 12, 2016: Semma Therapeutics Announces $5 Million Grant from California Institute of Regenerative Medicine to Develop Novel Stem-Cell Derived Treatment for Diabetes 37
Jun 29, 2016: Study Recommends Genomic Profiling to Diagnose Nonsmall Cell Lung Cancer Subtypes 38
Apr 03, 2016: Salmonella-Based Oral Vaccine Is A Potential Therapy For Preventing Type 1 Diabetes 40
Mar 31, 2016: City Of Hope awarded $2.5 million grant by the Conrad N. Hilton Foundation to launch nutrition initiative 41
Mar 16, 2016: City of Hope Research Team Receives $7.38 Million Grant from California’s Stem Cell Agency 43
Mar 03, 2016: City of Hope, Israel Cancer Research Fund Create Program for Cancer Research 44
Feb 08, 2016: City of Hope Scientists Create Technology to Target ‘Undruggable’ Diseases 45
Jan 21, 2016: City of Hope Receives $12 Million NCI Grant Supporting Innovative Cloud-Based Approach 46
Product News 47
May 01, 2017: City of Hope Researchers Find Regular Use of Aspirin Can Lower Risk of Breast Cancer for Women 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Tables
City of Hope, Pharmaceuticals & Healthcare, Key Facts 2
City of Hope, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
City of Hope, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
City of Hope, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
City of Hope, Deals By Therapy Area, 2011 to YTD 2017 9
City of Hope, Medical Devices Deals, 2011 to YTD 2017 10
City of Hope, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Helocyte Enters into Agreement with City of Hope for PepVax 13
Helocyte Enters into Agreement with City of Hope 14
Sorrento Therapeutics forms Joint Venture with City of Hope 15
Coronado Biosciences Forms Joint Venture with City of Hope 16
ModiQuest Research Enters Into Research Agreement With Beckman Research Institute 17
Mustang Bio Enters into Licensing Agreement with City of Hope 18
City of Hope Signs Licensing Agreement with Homology Medicines 19
Helocyte Exercises Option for Licensing Agreement with City of Hope for Pentamer 20
Mustang Bio Enters into Licensing Agreement with City of Hope 21
Helocyte Amends Agreement with City of Hope National Medical Center 22
Akriveia Therapeutics Enters into Licensing Agreement with City of Hope and Thomas Jefferson University 23
Beckman Research Institute Enters into Licensing Agreement with CEVEC Pharma 24
Tara Immuno-Oncology Therapeutics Enters into Licensing Agreement with City of Hope 25
Sorrento Therapeutics Enters into Licensing Agreement with City of Hope 26
Novonco Pharma Enters into Licensing Agreement with City of Hope 27
ES Cell International Enters into Licensing Agreement with Beckman Research Institute 28
City of Hope, Key Competitors 29
City of Hope, Key Employees 30
City of Hope, Other Locations 32
City of Hope, Subsidiaries 32
City of Hope, Joint Venture 33

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ City of Hope-製薬・医療分野:企業M&A・提携分析(City of Hope - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆